CRBP Corbus Pharmaceuticals Holdings, Inc.: institutional ownership and insider trading

117 funds reported holding $155M of Corbus Pharmaceuticals Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net bought $21.0M, with 23 new positions and 24 funds selling out; over the last 12 months insiders bought $126K and sold $1.13M on the open market.

CRBP revenue and earnings

Famous investors holding CRBP

Largest institutional holders of CRBP

  1. Cormorant Asset Management, LP — $22.0M
  2. ORBIMED ADVISORS LLC — $16.3M
  3. BlackRock, Inc. (BLK) — $12.5M
  4. Aberdeen Group plc — $12.4M
  5. DIADEMA PARTNERS LP — $8.77M
  6. VANGUARD CAPITAL MANAGEMENT LLC — $7.14M
  7. VANGUARD GROUP INC — $7.00M
  8. Jones Hill Capital LP — $6.13M
  9. Prosight Management, LP — $6.10M
  10. Caption Management, LLC — $5.63M

Recent CRBP insider trades

5%+ owners

Who owns the most CRBP stock?

The largest institutional holders of Corbus Pharmaceuticals Holdings, Inc. in the latest 13F filings are Cormorant Asset Management, LP ($22.0M), ORBIMED ADVISORS LLC ($16.3M), BlackRock, Inc. (BLK) ($12.5M).

Are insiders buying or selling CRBP?

Over the last 12 months insiders bought $126K and sold $1.13M of Corbus Pharmaceuticals Holdings, Inc. stock on the open market (SEC Form 4).

Which famous investors own CRBP?

Ken Griffin, Renaissance Technologies, Izzy Englander.

All CRBP 13F holders · All CRBP insider trades